# OnCo record miniprotein-radioconjugates (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/miniprotein-radioconjugates/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "miniprotein-radioconjugates" ;
  schema:name "Miniprotein radioconjugates"@en ;
  schema:alternateName "miniprotein radiopharmaceuticals"@en, "miniprotein radioligands"@en, "miniprotein radioconjugate platform"@en ;
  schema:description "A radioactive cancer medicine built on a small engineered protein instead of an antibody or a tiny peptide. It is meant to reach deep into a tumour, stay there, and leave the rest of the body quickly."@en ;
  schema:url <https://onco.cc/technologies/miniprotein-radioconjugates/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.aktisoncology.com/platform/>, <https://www.aktisoncology.com/pipeline/>, <https://clinicaltrials.gov/study/NCT07020117>, <https://clinicaltrials.gov/study/NCT07581184> ;
  onco:status "phase-1" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/targeted-alpha-therapy/> ;
  onco:targets <https://onco.cc/targets/nectin4/>, <https://onco.cc/targets/b7h3/> ;
  onco:companies <https://onco.cc/companies/aktis-oncology/> .